Safety Reporting (Pharmacovigilance)

OP has set up Pharmcovigilance system in compliance with Egyptian & EMEA regulations, to ensure that any untoward effects occurring in connection with the administration of any of OP products is identified, promptly collected and analyzed by experts and appropriately disseminated to make drug administration even safer and to prevent occurrence of adverse reactions.

OP is committed to improve patient care and safety by continuously monitoring unwanted effects and other safety aspects of drugs that are already in the market.

Various channels of communication are available to collect safety information round the clock.

You can contact our Patient Safety Department (Pharmacovigilance Department) and a member of our team can assist you on:

• October Pharma S.A.E, Street No. 25 - Plot 190 - 1st industrial zone
  6 October City, Giza - Egypt, PO Box: 38 - 6 October 12566
• (+2) 012 7414 5556 OR (+2) 012 7422 3711
• (+202) 3833 1907 - 3833 1902 - 3833 0652
• (+202) 3833 0653
• pv.dept@octoberpharma.com
•